Savage P - Search Results

1

The place of VEGF inhibition in the current management of renal cell carcinoma.

Nathan P, Chao D, Brock C, Savage P, Harries M, Gore M, Eisen T. Nathan P, et al. Among authors: savage p. Br J Cancer. 2006 May 8;94(9):1217-20. doi: 10.1038/sj.bjc.6603025. Br J Cancer. 2006. PMID: 16508632 Free PMC article. Review.

2

A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily.

Savage P, Horton V, Moore J, Owens M, Witt P, Gore ME. Savage P, et al. Br J Cancer. 1996 Nov;74(9):1482-6. doi: 10.1038/bjc.1996.569. Br J Cancer. 1996. PMID: 8912549 Free PMC article. Clinical Trial.

3

Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study.

Allen MJ, Vaughan M, Webb A, Johnston S, Savage P, Eisen T, Bate S, Moore J, Ahern R, Gore ME. Allen MJ, et al. Among authors: savage p. Br J Cancer. 2000 Oct;83(8):980-5. doi: 10.1054/bjoc.2000.1418. Br J Cancer. 2000. PMID: 10993642 Free PMC article. Clinical Trial.

4

The natural history and management of Merkel cell carcinoma of the skin: a review of 22 patients treated at the Royal Marsden Hospital.

Savage P, Constenla D, Fisher C, Thomas JM, Gore ME. Savage P, et al. Clin Oncol (R Coll Radiol). 1997;9(3):164-7. doi: 10.1016/s0936-6555(97)80073-8. Clin Oncol (R Coll Radiol). 1997. PMID: 9269548

5

A phase II study of continuous infusional 5-fluorouracil (5-FU) and subcutaneous interleukin-2 (IL-2) in metastatic renal cancer.

Savage P, Costelna D, Moore J, Gore ME. Savage P, et al. Eur J Cancer. 1997 Jun;33(7):1149-51. doi: 10.1016/s0959-8049(96)00515-1. Eur J Cancer. 1997. PMID: 9376197 Clinical Trial.

6

Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease.

Savage P, Constenla D, Fisher C, Shepherd JH, Barton DP, Blake P, Gore ME. Savage P, et al. Clin Oncol (R Coll Radiol). 1998;10(4):242-5. doi: 10.1016/s0936-6555(98)80008-3. Clin Oncol (R Coll Radiol). 1998. PMID: 9764376

7

The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer.

Horlock C, Stott B, Dyson PJ, Morishita M, Coombes RC, Savage P, Stebbing J. Horlock C, et al. Among authors: savage p. Br J Cancer. 2009 Apr 7;100(7):1061-7. doi: 10.1038/sj.bjc.6604963. Epub 2009 Mar 10. Br J Cancer. 2009. PMID: 19277040 Free PMC article.

8

Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014.

Savage P, Mahmoud S. Savage P, et al. Br J Cancer. 2015 Mar 17;112(6):1037-41. doi: 10.1038/bjc.2015.56. Br J Cancer. 2015. PMID: 25668005 Free PMC article.

9

Construction, characterisation and kinetics of a single chain antibody recognising the tumour associated antigen placental alkaline phosphatase.

Savage P, Rowlinson-Busza G, Verhoeyen M, Spooner RA, So A, Windust J, Davis PJ, Epenetos AA. Savage P, et al. Br J Cancer. 1993 Oct;68(4):738-42. doi: 10.1038/bjc.1993.420. Br J Cancer. 1993. PMID: 8398702 Free PMC article.

10

Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes.

Savage P, Cowburn P, Clayton A, Man S, McMichael A, Lemoine N, Epenetos A, Ogg G. Savage P, et al. Br J Cancer. 2002 Apr 22;86(8):1336-42. doi: 10.1038/sj.bjc.6600223. Br J Cancer. 2002. PMID: 11953895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,093 results

Search Page

Filters